Bayer

Activities: Ingredients Research & Development Pharmaceutical Dietary supplements Active Nutrition Food

Trending Articles

  1. Get ahead in the pharmaceutical industry with a Manufacturing Chemist subscription With a Manufacturing Chemist subscription you receive exclusive access to the latest news, technical insights, regulatory updates, and market intelligence
  2. Moderna bags $590m US investment to accelerate mRNA-based bird flu vaccine development The pharmaceutical company's investigational influenza vaccine targets the H5 and H7 varieties, and is currently being prepared for Phase III trials
  3. Servier expands AI partnership with Google Cloud to bolster pharma R&D efforts The company will utilise AI and generative AI technology to optimise its therapeutic target/drug discovery and development processes
  4. Kindeva Drug Delivery to supply nerve agent antidote autoinjector to the US SNS The CDMO will produce the DuoDote autoinjecter containing atropine and pralidoxime chloride at its fill/finish manufacturing facility in St Louis, Missouri
  5. Navin Molecular constructs a new R&D facility in Dewas, India The laboratory will enhance the CDMO's small molecule laboratory- and kilo-scale process development capabilities, as well as its analytical development and testing capacity

Upcoming event

Pharma Packaging and Labelling Forum

5–6 March 2025 | Conference | San Diego, US See all

Related Content

Regulatory

Bayer's acoramidis recommended for approval by the EMA's CHMP for cardiomyopathy

The orally administered transthyretin (TTR) stabiliser is suitable for patients with transthyretin amyloid cardiomyopathy, demonstrating at least a 90% TTR stabilisation capacity and a reduction in cardiovascular-related hospitalisations
Distribution

PanTera signs agreement with Bayer for the supply of actinium-225

The company will provide 225Ac for clinical trial needs
Research & Development

Recursion adds new chemical entity targeting fibrotic diseases to late discovery pipeline

Potential first-in-class molecule with novel target inlicensed from collaboration with Bayer
Packaging

Bayer joins the Blister Pack Collective to reduce single-use plastics in tablet packs

PA Consulting (PA), the company bringing ingenuity to life, and PulPac, the Swedish R&D and IP company behind Dry Molded Fiber, are pleased to announce the Consumer Health division of Bayer has joined the Blister Pack Collective
Ingredients

Therapeutic: asundexian for atrial fibrillation

In atrial fibrillation, the atria of the heart contract irregularly; as a result, they do not empty completely and prevent the correct flow of blood
Manufacturing

Topping-out ceremony for the world's first AI-enhanced drug production facility

Glatt is system integrator for a Bayer investment of around 275 million euros
Manufacturing

Bayer to implement Infor EAM at Bitterfield site

Implementation will be handled by Infor partner Rodias
Subscribe now